CHRONIC GRAFT VS. HOST DISEASE
Clinical trials for CHRONIC GRAFT VS. HOST DISEASE explained in plain language.
Never miss a new study
Get alerted when new CHRONIC GRAFT VS. HOST DISEASE trials appear
Sign up with your email to follow new studies for CHRONIC GRAFT VS. HOST DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Single patient gets expanded access to experimental GVHD drug
Disease control AVAILABLEThis program provides expanded access to axatilimab for one patient with chronic graft versus host disease (GVHD), a condition where donor immune cells attack the patient's body after a stem cell transplant. The treatment aims to control the disease, but patients typically need o…
Matched conditions: CHRONIC GRAFT VS. HOST DISEASE
Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for chinese patients with Hard-to-Treat chronic GVHD
Disease control Recruiting nowThis study tests the drug ruxolitinib in Chinese patients aged 12 and older who have chronic graft-versus-host disease (cGVHD) that did not improve with steroids. cGVHD is a complication after a stem cell transplant where the donor cells attack the patient's body. The main goal i…
Matched conditions: CHRONIC GRAFT VS. HOST DISEASE
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Major study aims to unlock secrets of chronic GVHD
Knowledge-focused Recruiting nowThis study follows 650 people with chronic graft-versus-host disease (cGVHD), a complication after stem cell transplant. Researchers collect medical data and samples over years to find markers that predict outcomes and improve care. The goal is to better understand the disease an…
Matched conditions: CHRONIC GRAFT VS. HOST DISEASE
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated May 17, 2026 10:41 UTC